U
SPPI

UBS’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

UBS’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$263K Sell
32,243
-30,485
-49% -$239K ﹤0.01% 4911
2014
Q2 		$510K Sell
62,728
-69,248
-52% -$525K ﹤0.01% 4207
2014
Q1 		$1.03M Sell
131,976
-33,669
-20% -$285K ﹤0.01% 3450
2013
Q4 		$1.47M Buy
165,645
+149,180
+906% +$1.33M ﹤0.01% 3131
2013
Q3 		$138K Sell
16,465
-6,659
-29% -$53.9K ﹤0.01% 5647
2013
Q2 		$173K Buy
+23,124
New +$177K ﹤0.01% 5264

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

UBS's SPPI Position: Q3 2014 in Review

UBS reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 49% in Q3 2014, selling an estimated $239K and leaving 32,243 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #4911.

UBS first reported a position in SPPI in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.47M in Q4 2013. 127 funds tracked by Wall St. Rank hold SPPI as of Q3 2014.

  • UBS held 32,243 shares of Spectrum Pharmaceuticals Inc worth $263K as of Q3 2014.
  • UBS sold 30,485 Spectrum Pharmaceuticals Inc shares in Q3 2014, an estimated $239K.
  • Spectrum Pharmaceuticals Inc made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4911 holding.
  • UBS first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and has held it in 6 quarters since.
  • UBS's Spectrum Pharmaceuticals Inc position peaked at $1.47M in Q4 2013.
  • 127 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.